Aegerion Pharmaceuticals, Inc.
19
1
1
16
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Low Risk
Score: 15/100
10.5%
2 terminated/withdrawn out of 19 trials
88.9%
+2.4% vs industry average
26%
5 trials in Phase 3/4
94%
15 of 16 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (19)
Immunogenicity of Metreleptin in Patients With Generalized Lipodystrophy
Role: lead
Familial Hypercholesterolemia Canada / Hypercholesterolemie Familiale Canada
Role: collaborator
Study to Determine the Intra-subject Variability of Pharmacokinetics of Lomitapide in Healthy Subjects
Role: lead
Evaluate the Effect of Atorvastatin on the Pharmacokinetics of Lomitapide in Healthy Subjects.
Role: lead
Evaluate the Effect of Ethinyl Estradiol/Norgestimate on the Pharmacokinetics of Lomitapide in Healthy Female Subjects
Role: lead
Phase I Study of the Safety, Tolerability, PK & PD of Lomitapide in Japanese and Caucasian Subjects With Elevated LDL-C
Role: lead
Efficacy and Safety of Lomitapide in Japanese Patients With HoFH on Concurrent Lipid-Lowering Therapy
Role: lead
Long Term, Follow-on Study of Lomitapide in Patients With Homozygous Familial Hypercholesterolemia
Role: lead
AEGR-733 and Atorvastatin 20 mg vs. Monotherapy in Moderate Hypercholesterolemia
Role: lead
A Safety and Efficacy Study of AEGR-733 to Treat Homozygous Familial Hypercholesterolemia (FH)
Role: lead
Evaluate Low Doses of AEGR-733 on Hepatic Fat Accumulation by MRS
Role: lead
Pharmacokinetic Drug Interactions of AEGR-733 on Lipid-lowering Agents
Role: lead
Evaluate Safety and Efficacy of AEGR-733 and Atorvastatin vs Atorvastatin Monotherapy in Hypercholesterolemia
Role: lead
Evaluate the Efficacy and Safety of Lomitapide in Pediatric Patients With Homozygous Familial Hypercholesterolemia on Stable Lipid-lowering Therapy
Role: lead
A Comparative Bioavailability Study of Lomitapide 20 mg Intact vs Sprinkled
Role: lead
Effects of Lomitapide on Carotid and Aortic Atherosclerosis
Role: lead
Detection of Familial Hypercholesterolaemia in Cardiovascular Disease Registry
Role: collaborator
The Safety & Efficacy of Combination BMS-201038 (AEGR-733) & Ezetimibe vs. Monotherapy in Moderate Hypercholesterolemia
Role: lead
Safety, Tolerability and Efficacy of Microsomal Triglyceride Protein (MTP) Inhibitor
Role: lead
All 19 trials loaded